Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Short Interest Update

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 11,500 shares, a decline of 79.1% from the January 15th total of 55,100 shares. Based on an average daily volume of 185,500 shares, the short-interest ratio […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom , ,Cambridge Investment Research Advisors Inc ,Hedge Funds Weigh In On Galmed Pharmaceuticals ,Walleye Capital ,Galmed Pharmaceuticals Ltd ,Nasdaq ,Galmed Pharmaceuticals Company Profile ,Raymond James Financial Services Advisors Inc ,Millennium Management ,Galmed Pharmaceuticals Trading ,Galmed Pharmaceuticals ,News Ratings For Galmed Pharmaceuticals Daily ,Get Free Report ,Investment Research Advisors ,James Financial Services Advisors ,Pharmaceuticals Ltd ,Galmed Pharmaceuticals Daily ,Nasdaq Glmd ,Glmd ,Medical ,Stocks ,Options ,Put ,Call ,